Palumbo Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$523K Buy
1,486
+10
+0.7% +$3.56K 0.13% 124
2025
Q4
$483K Buy
1,476
+87
+6% +$27.6K 0.12% 127
2025
Q3
$377K Sell
1,389
-51
-4% -$14.8K 0.12% 115
2025
Q2
$402K Sell
1,440
-61
-4% -$17.3K 0.12% 121
2025
Q1
$468K Buy
1,501
+122
+9% +$36K 0.16% 98
2024
Q4
$359K Buy
1,379
+43
+3% +$12.8K 0.13% 108
2024
Q3
$430K Buy
1,336
+12
+0.9% +$3.92K 0.17% 94
2024
Q2
$414K Buy
1,324
+25
+2% +$7.34K 0.17% 90
2024
Q1
$369K Buy
1,299
+10
+0.8% +$2.93K 0.17% 95
2023
Q4
$371K Buy
1,289
+218
+20% +$59.4K 0.19% 90
2023
Q3
$288K Buy
1,071
+2
+0.2% +$499 0.16% 89
2023
Q2
$237K Buy
+1,069
New +$248K 0.15% 93

Other funds holding AMGN

Palumbo Wealth Management's AMGN Position: Q1 2026 in Review

Palumbo Wealth Management increased its Amgen (AMGN) stake by 0.68% in Q1 2026, buying an estimated $3.56K and bringing the position to 1,486 shares worth $523K. The position accounts for 0.13% of the portfolio, ranked #124.

Palumbo Wealth Management first reported a position in AMGN in Q2 2023 and has held it in 12 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Palumbo Wealth Management held 1,486 shares of Amgen worth $523K as of Q1 2026.
  • Palumbo Wealth Management bought 10 Amgen shares in Q1 2026, an estimated $3.56K.
  • Amgen made up 0.13% of Palumbo Wealth Management's portfolio in Q1 2026, its #124 holding.
  • Palumbo Wealth Management first reported a position in Amgen in Q2 2023 and has held it in 12 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Palumbo Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.